PFM Health Sciences, LP - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of PULMONX CORP
ValueSharesWeighting
Q4 2022$12,272,141
+268.9%
1,455,770
+629.0%
0.44%
+265.8%
Q3 2022$3,327,000
-50.4%
199,703
-4.5%
0.12%
-47.4%
Q4 2021$6,709,000
+36.5%
209,193
+53.2%
0.23%
+58.3%
Q3 2021$4,914,000
-18.5%
136,5760.0%0.14%
-23.8%
Q2 2021$6,026,000
-3.5%
136,5760.0%0.19%
-1.0%
Q1 2021$6,247,000
-69.2%
136,576
-54.9%
0.19%
-73.2%
Q4 2020$20,260,000302,6310.71%
Other shareholders
PULMONX CORP shareholders Q1 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders